Pfizer Global Medical Grants Announces a New QI RFP in Breast Cancer
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.
- Date RFP Issued: March 19, 2024
- Geographic Scope: Spain
- Clinical Area: Oncology, Breast tumors
- Link to full RFP: Reducing Barriers to Optimal Clinical Care in Breast Cancer
- Application Due Date: May 20, 2024
- Specific Area of Interest: The intent of this RFP is to support independent quality improvement initiatives based on innovative digital tools or electronic care-delivery channels that will reduce barriers to optimal care of people with BC. Example issues to address might include but are not limited to management of side effects, improving frequency or efficiency of HCP/patient communications, or increasing awareness of or access to clinical trials.
Projects that will be considered for Pfizer support will focus on:
• Health gadgets, apps, websites, devices, ePRO platforms, etc. to improve the assistance of BC patients.
• Multi-center collaborative projects or multidisciplinary projects in the same center to find potential assistance gaps and address them through digital tools.
• Collaborations between healthcare professionals and patient advocacy groups in terms of digital channels.
Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Jacqueline Waldrop, Grant Officer (Jacqueline.Waldrop@pfizer.com).